Trevi Therapeutics, Inc. (TRVI)
NASDAQ: TRVI · Real-Time Price · USD
10.56
-0.40 (-3.65%)
Jan 28, 2026, 10:54 AM EST - Market open
Trevi Therapeutics Analyst Ratings
Total Analysts
12
Consensus Rating
Strong Buy
Price Target
$20.38
Upside
+92.99%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $21 | Strong Buy | Reiterates | $21 | +98.86% | Jan 9, 2026 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $19 | Strong Buy | Maintains | $19 | +79.92% | Jan 8, 2026 |
| Stifel | Stifel | Strong Buy Maintains $15 → $18 | Strong Buy | Maintains | $15 → $18 | +70.45% | Dec 19, 2025 |
| Leerink Partners | Leerink Partners | Buy Maintains $13 → $16 | Buy | Maintains | $13 → $16 | +51.52% | Nov 20, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $19 | Strong Buy | Maintains | $19 | +79.92% | Nov 14, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $23 → $24 | Buy | Maintains | $23 → $24 | +127.27% | Nov 14, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $18 → $19 | Buy | Maintains | $18 → $19 | +79.92% | Nov 14, 2025 |
| Clear Street | Clear Street | Strong Buy Maintains $11 → $21 | Strong Buy | Maintains | $11 → $21 | +98.86% | Nov 14, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Initiates $18 | Buy | Initiates | $18 | +70.45% | Aug 21, 2025 |
| Raymond James | Raymond James | Strong Buy Maintains $29 → $27 | Strong Buy | Maintains | $29 → $27 | +155.68% | Aug 8, 2025 |
| Needham | Needham | Strong Buy Maintains $24 → $22 | Strong Buy | Maintains | $24 → $22 | +108.33% | Aug 8, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $25 | Buy | Initiates | $25 | +136.74% | Jul 1, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $21 | Strong Buy | Maintains | $21 | +98.86% | Jun 2, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $21 | Strong Buy | Initiates | $21 | +98.86% | May 28, 2025 |
| Needham | Needham | Strong Buy Reiterates $24 | Strong Buy | Reiterates | $24 | +127.27% | May 20, 2025 |
| Needham | Needham | Strong Buy Reiterates $24 | Strong Buy | Reiterates | $24 | +127.27% | Apr 8, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.